Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019
May 13, 2019 at 04:50 pm EDT
Share
Easywell Biomedicals, Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 83.724 million compared to TWD 92.196 million a year ago. Operating loss was TWD 54.252 million compared to TWD 51.634 million a year ago. Net loss was TWD 62.556 million compared to TWD 53.773 million a year ago. Basic loss per share from continuing operations was TWD 0.53 compared to TWD 0.49 a year ago. Basic loss per share was TWD 0.6 compared to TWD 0.54 a year ago.
Easywell Biomedicals Inc. is a Taiwan-based company principally engaged in the research, development, production and sale of raw materials and temperature measurement products. The raw materials are applied in the manufacture of medicament for the treatment of epilepsy, pain and fever, antihypertensive and diuretic, skeletal muscle relaxants, among others. The Company's diagnostic devices include ear thermometers and digital clinical thermometers. The Company distributes its products mainly in Taiwan, the Americas and Europe.
EASYWELL BIOMEDICALS, INC. 
